The global cervical dysplasia treatment market is on a trajectory of steady expansion, with projections indicating a rise from USD 628.5 million in 2023 to USD 846.2 million by 2033. This growth, at a ...

The U.S. Food and Drug Administration on Friday approved Teal Health to provide the nation's first at-home test kit to screen for cervical cancer.

The FDA has approved the first and only self-collection cervical cancer screening device, where patients can obtain their own samples from the comfort of their own home. The Teal Wand, manufactured by ...

his year’s World Immunization Week, which ran from April 24 to 30, highlighted Indonesia’s ongoing struggle to combat cervical cancer, which continues to pose a significant health burden in ...

Tivdak is a first-in-class therapy that combines an antibody target at tissue factor – a protein expressed on cervical cancer cells – with a cell-killing drug called monomethyl auristatin E.

Clinical heterogeneity, unpredictable course and flares are characteristics of systemic lupus erythematosus (SLE). Although SLE is—by and large—a systemic disease, occasionally it can be ...